Sympatient

Anxiety is the most prevalent mental psychiatric disorder affecting more than 250 million people worldwide. Because of a shortage of therapy places, patients have to wait for months before they can start treatment. Sympatient has taken the gold-standard of care, exposure therapy, and has made it available on-demand and in the comfort of a patient's own home. Sympatient's pioneering approach combines a self-guided immersive experience with additional phone consultations by a trained psychologist. Assuring the same outcome as traditional therapy, it is more convenient and 4 times less expensive. In Germany alone, where 1 million new patients are diagnosed every year, the direct savings potential for health insurers amounts to EUR 2.8 billion per year.
Sympatient logo
Christian Angern about Verve Ventures
Verve Ventures has introduced us to several valuable advisors already and is there for us when we need them: With pragmatic and actionable advice.
Founders / Management Christian Angern, Julian Angern, Benedikt Reinke
Sectors Health & Bio, Mental Health, Virtual Reality
Located in Germany
Co-Investors IFH
Follow On

LinkedIn

Sign up to receive our weekly newsletter and learn about investing in technologies that are changing the world.